Back to Search
STEPHEN GLUCK, MD
MD
Internal Medicine Physician
NPI: 1982650115IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
G84102(CA)
Nephrology Physician
Internal Medicine — Nephrology
Code: 207RN0300X
G84102(CA)
Education
UNIVERSITY OF CALIFORNIA, GEFFEN SCHOOL OF MEDICINE
Class of 1977
Research & Publications (20)
Evaluation of NO(x) flue gas analyzers for accuracy and their applicability for low-concentration measurements.
PMID 12828335·J Air Waste Manag Assoc·2003
8-other
A Phase II trial of split, low-dose docetaxel and low-dose capecitabine: a tolerable and efficacious regimen in the first-line treatment of patients with HER2/neu-negative metastatic breast cancer.
PMID 18621613·Clin Breast Cancer·2008
3-trial
Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16.
PMID 18025439·J Clin Oncol·2008
4-observational
IFN-gamma regulation of vacuolar pH, cathepsin D processing and autophagy in mammary epithelial cells.
PMID 18494001·J Cell Biochem·2008
8-other
Physical interaction between aldolase and vacuolar H+-ATPase is essential for the assembly and activity of the proton pump.
PMID 17576770·J Biol Chem·2007
8-other
Paclitaxel albumin-bound particles (abraxane) in combination with bevacizumab with or without gemcitabine: early experience at the University of Miami/Braman Family Breast Cancer Institute.
PMID 17913443·Biomed Pharmacother·2007
8-other
Health economics in the Journal of Clinical Oncology and an evaluation of the indirect costs and benefits associated with adjuvant trastuzumab.
PMID 17664490·J Clin Oncol·2007
8-other
Sequential response-adapted induction and consolidation regimens idarubicin/cytarabine and mitoxantrone/etoposide in adult acute myelogenous leukemia: 10 year follow-up of a study by the Canadian Leukemia Studies Group.
PMID 16690529·Leuk Lymphoma·2006
3-trial
Concomitant low-dose cisplatin and three-dimensional conformal radiotherapy for locally advanced squamous cell carcinoma of the head and neck: Analysis of survival and toxicity.
PMID 16265658·Head Neck·2006
8-other
Distribution of Rab GTPases in mouse kidney and comparison with vacuolar H+-ATPase.
PMID 15838183·Nephron Physiol·2005
4-observational
Phosphatidylinositol 3-kinase-mediated effects of glucose on vacuolar H+-ATPase assembly, translocation, and acidification of intracellular compartments in renal epithelial cells.
PMID 15632060·Mol Cell Biol·2005
8-other
The glycolytic enzyme aldolase mediates assembly, expression, and activity of vacuolar H+-ATPase.
PMID 14672945·J Biol Chem·2004
8-other
Vacuolar H+-ATPase binding to microfilaments: regulation in response to phosphatidylinositol 3-kinase activity and detailed characterization of the actin-binding site in subunit B.
PMID 14662773·J Biol Chem·2004
7-preclinical
Direct injection GC method for measuring light hydrocarbon emissions from cooling-tower water.
PMID 14717185·Environ Sci Technol·2003
8-other
Interstitial collagenase activity stimulates the formation of actin rings and ruffled membranes in mouse marrow osteoclasts.
PMID 12522662·Calcif Tissue Int·2003
7-preclinical
Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor-positive advanced breast carcinoma.
PMID 12436453·Cancer·2002
8-other
Phase II study of sequential topotecan and etoposide in patients with intermediate grade non-Hodgkin's lymphoma: a National Cancer Institute of Canada Clinical Trials Group study.
PMID 12400600·Leuk Lymphoma·2002
3-trial
The amino-terminal domain of the E subunit of vacuolar H(+)-ATPase (V-ATPase) interacts with the H subunit and is required for V-ATPase function.
PMID 12163484·J Biol Chem·2002
8-other
Interaction between aldolase and vacuolar H+-ATPase: evidence for direct coupling of glycolysis to the ATP-hydrolyzing proton pump.
PMID 11399750·J Biol Chem·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 400 PARNASSUS AVE
SAN FRANCISCO, CA 94143 - Phone
- (415) 353-2507
Quick Facts
- NPI
- 1982650115
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 49
- Publications
- 20
Are you this provider?
Claim Your Profile